• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有残余嗜睡的阻塞性睡眠呼吸暂停患者的临床特征

Clinical characteristics of obstructive sleep apnoea patients with residual sleepiness.

作者信息

Feng Xujun, Zhang Ye, Shi Yuan, Ren Rong, Lei Fei, Vitiello Micheal V, Tang Xiangdong

机构信息

Sleep Medicine Center, Department of Respiratory and Critical Care Medicine, Mental Health Center, West China Hospital, Sichuan University, Chengdu, China.

These authors share the first authorship.

出版信息

ERJ Open Res. 2025 Apr 14;11(2). doi: 10.1183/23120541.00682-2024. eCollection 2025 Mar.

DOI:10.1183/23120541.00682-2024
PMID:40230430
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11995279/
Abstract

OBJECTIVE

This meta-analysis examines the clinical characteristics of continuous positive airway pressure (CPAP)-treated obstructive sleep apnoea (OSA) patients with residual excessive sleepiness (RES).

METHOD

We conducted a search for articles published from inception to 16 March 2024 in PubMed, Embase, Cochrane Library and Web of Science. Seven studies were included in this meta-analysis.

RESULTS

The meta-analysis revealed that CPAP-treated OSA patients with RES were characterised by higher Epworth sleepiness scale and depression scale scores, lower body mass index (BMI) and apnoea-hypopnoea index (AHI) before CPAP treatment. RES patients also exhibit poorer CPAP adherence. Being female was also associated with RES.

CONCLUSION

Being female, having lower BMI and AHI, more severe daytime sleepiness and depressive symptoms before CPAP treatment, and lower CPAP adherence were characteristics of OSA patients with RES. These factors may prove helpful in identifying CPAP-treated OSA patients who may need additional treatment to minimise RES.

摘要

目的

本荟萃分析探讨持续气道正压通气(CPAP)治疗的阻塞性睡眠呼吸暂停(OSA)患者伴有残余过度嗜睡(RES)的临床特征。

方法

我们检索了从创刊至2024年3月16日在PubMed、Embase、Cochrane图书馆和科学网发表的文章。本荟萃分析纳入了7项研究。

结果

荟萃分析显示,CPAP治疗的伴有RES的OSA患者的特征为,在CPAP治疗前,Epworth嗜睡量表和抑郁量表得分较高,体重指数(BMI)和呼吸暂停低通气指数(AHI)较低。RES患者的CPAP依从性也较差。女性也与RES有关。

结论

女性、BMI和AHI较低、CPAP治疗前白天嗜睡和抑郁症状较严重以及CPAP依从性较低是伴有RES的OSA患者的特征。这些因素可能有助于识别CPAP治疗的OSA患者中可能需要额外治疗以尽量减少RES的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e929/11995279/461a91b73f9a/00682-2024.04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e929/11995279/63e0464e1299/00682-2024.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e929/11995279/2cd60ccff32b/00682-2024.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e929/11995279/7de02ad370bb/00682-2024.03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e929/11995279/461a91b73f9a/00682-2024.04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e929/11995279/63e0464e1299/00682-2024.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e929/11995279/2cd60ccff32b/00682-2024.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e929/11995279/7de02ad370bb/00682-2024.03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e929/11995279/461a91b73f9a/00682-2024.04.jpg

相似文献

1
Clinical characteristics of obstructive sleep apnoea patients with residual sleepiness.伴有残余嗜睡的阻塞性睡眠呼吸暂停患者的临床特征
ERJ Open Res. 2025 Apr 14;11(2). doi: 10.1183/23120541.00682-2024. eCollection 2025 Mar.
2
Pressure modification or humidification for improving usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea.压力调节或湿化以改善阻塞性睡眠呼吸暂停成人患者持续气道正压通气机的使用情况。
Cochrane Database Syst Rev. 2019 Dec 2;12(12):CD003531. doi: 10.1002/14651858.CD003531.pub4.
3
Polysomnography in patients with obstructive sleep apnea: an evidence-based analysis.阻塞性睡眠呼吸暂停患者的多导睡眠图:一项基于证据的分析。
Ont Health Technol Assess Ser. 2006;6(13):1-38. Epub 2006 Jun 1.
4
Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea.针对阻塞性睡眠呼吸暂停的肌功能治疗(口咽运动训练)
Cochrane Database Syst Rev. 2020 Nov 3;11(11):CD013449. doi: 10.1002/14651858.CD013449.pub2.
5
Drug therapy for obstructive sleep apnoea in adults.成人阻塞性睡眠呼吸暂停的药物治疗
Cochrane Database Syst Rev. 2013 May 31;2013(5):CD003002. doi: 10.1002/14651858.CD003002.pub3.
6
Clinical effectiveness and cost-effectiveness results from the randomised controlled Trial of Oral Mandibular Advancement Devices for Obstructive sleep apnoea-hypopnoea (TOMADO) and long-term economic analysis of oral devices and continuous positive airway pressure.阻塞性睡眠呼吸暂停低通气综合征口腔下颌前移装置随机对照试验(TOMADO)的临床疗效和成本效益结果以及口腔装置与持续气道正压通气的长期经济分析。
Health Technol Assess. 2014 Oct;18(67):1-296. doi: 10.3310/hta18670.
7
Continuous positive airways pressure for obstructive sleep apnoea in adults.成人阻塞性睡眠呼吸暂停的持续气道正压通气
Cochrane Database Syst Rev. 2006 Jan 25(1):CD001106. doi: 10.1002/14651858.CD001106.pub2.
8
Residual sleepiness in veterans with post-traumatic stress disorder and obstructive sleep apnea.创伤后应激障碍和阻塞性睡眠呼吸暂停退伍军人的残余嗜睡。
Sleep Breath. 2023 Jun;27(3):853-860. doi: 10.1007/s11325-022-02678-z. Epub 2022 Jul 8.
9
Continuous positive airways pressure for obstructive sleep apnoea in adults.成人阻塞性睡眠呼吸暂停的持续气道正压通气治疗
Cochrane Database Syst Rev. 2006 Jul 19(3):CD001106. doi: 10.1002/14651858.CD001106.pub3.
10
Predictors of the Efficacy for Daytime Sleepiness in Patients With Obstructive Sleep Apnea With Continual Positive Airway Pressure Therapy: A Meta-Analysis of Randomized Controlled Trials.持续气道正压通气治疗阻塞性睡眠呼吸暂停患者日间嗜睡疗效的预测因素:一项随机对照试验的荟萃分析
Front Neurol. 2022 Jun 27;13:911996. doi: 10.3389/fneur.2022.911996. eCollection 2022.

本文引用的文献

1
Sleep and cardiometabolic comorbidities in the obstructive sleep apnoea-COPD overlap syndrome: data from the European Sleep Apnoea Database.阻塞性睡眠呼吸暂停-慢性阻塞性肺疾病重叠综合征中的睡眠与心脏代谢共病:来自欧洲睡眠呼吸暂停数据库的数据
ERJ Open Res. 2023 Jun 26;9(3). doi: 10.1183/23120541.00676-2022. eCollection 2023 May.
2
Investigating the Relationship between Obstructive Sleep Apnoea, Inflammation and Cardio-Metabolic Diseases.探讨阻塞性睡眠呼吸暂停、炎症与心血管代谢疾病的关系。
Int J Mol Sci. 2023 Apr 6;24(7):6807. doi: 10.3390/ijms24076807.
3
Obstructive sleep apnoea heterogeneity and cardiovascular disease.
阻塞性睡眠呼吸暂停异质性与心血管疾病。
Nat Rev Cardiol. 2023 Aug;20(8):560-573. doi: 10.1038/s41569-023-00846-6. Epub 2023 Mar 10.
4
International Consensus Statement on Obstructive Sleep Apnea.国际阻塞性睡眠呼吸暂停共识声明。
Int Forum Allergy Rhinol. 2023 Jul;13(7):1061-1482. doi: 10.1002/alr.23079. Epub 2023 Mar 30.
5
Predictors of the Efficacy for Daytime Sleepiness in Patients With Obstructive Sleep Apnea With Continual Positive Airway Pressure Therapy: A Meta-Analysis of Randomized Controlled Trials.持续气道正压通气治疗阻塞性睡眠呼吸暂停患者日间嗜睡疗效的预测因素:一项随机对照试验的荟萃分析
Front Neurol. 2022 Jun 27;13:911996. doi: 10.3389/fneur.2022.911996. eCollection 2022.
6
Residual sleepiness in veterans with post-traumatic stress disorder and obstructive sleep apnea.创伤后应激障碍和阻塞性睡眠呼吸暂停退伍军人的残余嗜睡。
Sleep Breath. 2023 Jun;27(3):853-860. doi: 10.1007/s11325-022-02678-z. Epub 2022 Jul 8.
7
Investigation and management of residual sleepiness in CPAP-treated patients with obstructive sleep apnoea: the European view.CPAP 治疗阻塞性睡眠呼吸暂停患者残余嗜睡的调查和管理:欧洲观点。
Eur Respir Rev. 2022 May 25;31(164). doi: 10.1183/16000617.0230-2021. Print 2022 Jun 30.
8
Dose-response relationship between positive airway pressure therapy and excessive daytime sleepiness: the HomePAP study.正压通气治疗与日间过度嗜睡的剂量反应关系:HomePAP 研究。
J Clin Sleep Med. 2022 Apr 1;18(4):1027-1034. doi: 10.5664/jcsm.9792.
9
Excessive Daytime Sleepiness in Obstructive Sleep Apnea Patients Treated With Continuous Positive Airway Pressure: Data From the European Sleep Apnea Database.持续气道正压通气治疗的阻塞性睡眠呼吸暂停患者的日间过度嗜睡:来自欧洲睡眠呼吸暂停数据库的数据。
Front Neurol. 2021 Aug 9;12:690008. doi: 10.3389/fneur.2021.690008. eCollection 2021.
10
Residual excessive daytime sleepiness in patients treated for obstructive sleep apnea: guidance for assessment, diagnosis, and management.治疗阻塞性睡眠呼吸暂停后仍存在日间过度嗜睡的患者:评估、诊断和管理指南。
Postgrad Med. 2021 Sep;133(7):772-783. doi: 10.1080/00325481.2021.1948305. Epub 2021 Jul 22.